Identification Of Brain Regions Involved In The Regulation Of Coughing
Funder
National Health and Medical Research Council
Funding Amount
$431,146.00
Summary
Cough is a symptom of more than 100 clinical conditions of the respiratory system, and is the most common reason that people seek medical advice. However, currently available cough suppresant drugs are at best only modestly effective at treating cough disorders. In this study we aim to better understand how the brain regulates coughing in the hope to identify new therapeutic targets for relieving cough.
Gabapentin In The Treatment Of Idiopathic Chronic Cough: A Randomised Double-blind Placebo-controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$331,229.00
Summary
Better treatment approaches are needed to address the significant quality of life impairment associated with chronic cough. We propose to conduct a double-blind, placebo controlled study comparing the efficacy (and safety) of oral gabapentin therapy on cough reflex severity and cough-specific quality of life in people with idiopathic cough. The advantages are a strong design, use of objective assessment techniques, and investigation of a new treatment modality for cough.
Pregabalin And Speech Pathology Treatment For Refractory Chronic Cough With Laryngeal Hypersensitivity
Funder
National Health and Medical Research Council
Funding Amount
$155,747.00
Summary
Persistent cough that does not respond to medical treatment is debilitating and frustrating for the sufferer and very expensive for the Australian government. This research will provide a new and effective treatment option and extend our current reputation as the world leader in the identification and treatment of refractory chronic cough. This treatment strategy has not been trialled before and the findings will change current medical practice and significantly reduce community health costs.
Early Detection Of Pulmonary Exacerbation In Cystic Fibrosis Using Nocturnal Measurements Of Cough And Sleep
Funder
National Health and Medical Research Council
Funding Amount
$140,949.00
Summary
Cystic Fibrosis (CF), the most common lethal inherited disorder effecting Australians, is a medical success story, with survival increasing from 5 years in 1970 to 40 years now. However, lower respiratory tract infections remain the major problem in CF. This project will develop and test a simple, non-invasive device to detect early chest infections, allowing early treatment, improving quality of life and preventing lung scarring. Less hospitalisations will benefit both patients and hospitals.